Clinical Trial Detail

NCT ID NCT01196390
Title Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma


Carboplatin + Paclitaxel + Trastuzumab

Carboplatin + Paclitaxel

Age Groups: senior adult

Additional content available in CKB BOOST